Increased levels of cyclic adenosine monophosphate contribute to the hyporesponsiveness of mast cells in alloxan diabetes

International Immunopharmacology

Volumn 4, Issue 6, 2004, Pages 755-762

  Barreto, Emiliano O ^a   Carvalho, Vinicius F ^a   Lagente, Vincent ^b   Lugnier, Claire ^c   Cordeiro, Renato S B ^a   Martins, Marco A ^a   E Silva, Patrícia M R ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITÉ DE RENNES 1   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

cAMP; Diabetes; Mast cells

Indexed keywords

9 (2 FLUOROBENZYL) 6 N METHYL 2 TRIFLUOROMETHYLADENINE; ANTIGEN; AZELASTINE; BRADYKININ; BUCLADESINE; COMPOUND 48-80; CYCLIC AMP; INSULIN; PHOSPHODIESTERASE INHIBITOR; PICLAMILAST; ROLIPRAM;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; HISTAMINE RELEASE; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; MAST CELL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; ANTIGENS; BRADYKININ; BUCLADESINE; CELL DEGRANULATION; CELL SEPARATION; CYCLIC AMP; DIABETES MELLITUS, EXPERIMENTAL; DINITROPHENOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOGLOBULIN E; MALE; MAST CELLS; P-METHOXY-N-METHYLPHENETHYLAMINE; PHOSPHODIESTERASE INHIBITORS; PLEURA; RATS; ROLIPRAM; STIMULATION, CHEMICAL;

EID: 2342507586     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.03.001     Document Type: Article

References (26)

1. Lasser E. Asthma and diabetes mellitus: a biochemical basis for antithetical features. Med. Hypotheses. 23:1987;95-106
2. Pereira M.A.A., Sannomiya P., Garcia-Leme J. Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetes rat plasma. Diabetes. 36:1987;1307-1314
3. Fortes Z.B., Farsky S.H.P., Oliveira M.A., Garcia-Leme J. Direct vital microscopic study of defective leukocyte-endothelial interaction in diabetes mellitus. Diabetes. 40:1991;1267-1273
4. Diaz B.L., Serra M.F., Alves A.C., Pires A.L.A., Corrêa F.M.A., Cordeiro R.S.B., et al. Alloxan diabetes reduces pleural mast cell numbers and subsequent eosinophil influx induced by allergen in sensitized rats. Int. Arch. Allergy Immunol. 111:1996;36-43
5. Diaz B., Barreto E., Cordeiro R., Perretti M., Martins M., Silva P. Enhanced serum glucocorticoid levels mediate the reduction of serosal mast cell numbers in diabetic rats. Life Sci. 68:2001;2925-2932
6. de Oliveira Barreto E., de Frias Carvalho V., Diaz B.L., Balduino A., Cordeiro R.S.B., Martins M.A., et al. Adoptive transfer of mast cells abolishes the inflammatory refractoriness to allergen in diabetic rats. Int. Arch. Allergy Immunol. 131:2003;212-220
7. Parker C.W., Huber M.G., Baumann M.L. Alterations of cyclic AMP metabolism in human bronchial asthma: III. Leukocyte and lymphocyte responses to steroids. J. Clin. Invest. 52:1973;1342-1348
8. Essayan D.M. Cyclic nucleotide phosphodiesterases. J. Allergy Clin. Immunol. 108:2001;671-680
9. Chong L.K., Morice A.H., Yeo W.W., Schleimer R.P., Peachell P.T. Functional desensitization of beta agonist responses in human lung mast cell. Am. J. Respir. Cell Mol. Biol. 13:1995;540-546
10. Shore P.A., Burkhalter A., Cohn V.H. A method for the fluorimetric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 127:1959;182-186
11. Boichot E., Wallace J.L., Germain N., Corbel M., Lugnier C., Lagente V., et al. Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derived from 9-benzyladenine. J. Pharmacol. Exp. Ther. 292:2000;647-653
12. Weston M.C., Anderson N., Peachell P.T. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function. Br. J. Pharmacol. 121:1997;287-295
13. Casacó A., Carvajal D., Tolon Z. Diabetes-induced hyposensitivity to compound 48/80. Can. J. Physiol. Pharmacol. 69:1991;886-888
14. Holgate S.T. The role of mast cells and basophils in inflammation. Clin. Exp. Allergy. 30(Suppl. 1):2000;28-32
15. Chan O., Chan S., Inouye K., Vranic M., Matthews S. Molecular regulation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induced diabetes: effect of insulin treatment. Endocrinology. 142:2001;4872-4879
16. Carvalho V.F., Barreto E.O., Diaz B.L., Serra M.F., Azevedo V., Cordeiro R.S., et al. Systemic anaphylaxis is prevented in alloxan-diabetic rats by a mechanism dependent on glucocorticoid. Eur. J. Pharmacol. 472:2003;221-227
17. Diaz B.L., Serra M.F., Barreto E.O., Cordeiro R.S., Martins M.A., Silva P.M. Antigen-induced pleural eosinophilia is suppressed in diabetic rats: role of corticosteroid hormones. Mem. Inst. Oswaldo Cruz. 92(Suppl. 2):1997;219-222
18. Marone G., Lichtenstein L.M., Plaut M. Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3′:5′-monophosphate and potentiation of adenylate cyclase-activating agents. J. Pharmacol. Exp. Ther. 215:1980;469-478
19. Baus E., Van Laethem F., Andris F., Rolim S., Urbain J., Leo O. Dexamethasone increases intracellular cyclic AMP concentration in murine T lymphocyte cell lines. Steroid. 66:2001;39-47
20. Shichijo M., Inagaki N., Kimata M., Serizawa I., Saito H., Nagai H. Role of cyclic 3′, 5′-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cells. J. Allergy Clin. Immunol. 103:1999;S421-S428
21. Goldsmith P., McGarity B., Walls A.F., Church M.K., Millward-Sadler G.H., Robertson D.A. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig. Dis. Sci. 35:1990;1409-1413
22. Abdel-Halim S.M., Guenifi A., He B., Yang B., Mustafa M., Hojeberg B., et al. Mutations in the promoter of adenylyl cyclase (AC)-III gene, overexpression of AC-III mRNA, and enhanced cAMP generation in islets from the spontaneously diabetic GK rat model of type 2 diabetes. Diabetes. 47:1998;498-504
23. Janka H.U., Standl E., Schramm W., Mehnert H. Platelet enzyme activities in diabetes mellitus in relation to endothelial damage. Diabetes. Suppl. 2:1983;47-51
24. Edelstein D., Brownlee M. Mechanistic studies of advanced glycosilation and product inhibition by aminoguanidine. Diabetes. 41:1992;26-29
25. Guenifi A., Abdel-Halim S.M. Glucose enhances adenylyl clyclase responses in normal but not diabetic GK rat islets. Pancreas. 22:2000;65-68
26. Alves A.C., Pires A.L.A., Cruz H.N., Serra M.F., Diaz B.L., Cordeiro R.S.B., et al. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro. Eur. J. Pharmacol. 312:1996;89-96